Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Bibliographic Details
Main Authors:	Selin Küçükyurt, Alihan Kelezoğlu, Tuğrul Elverdi, Deniz Özmen, Muhlis Cem Ar, Ahmet Emre Eşkazan
Format:	Article
Language:	English
Published:	Elsevier 2023-04-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137921000821

Similar Items

Acute Thrombocytopenia Complicating the Initial Administration of Obinutuzumab: Is It More Frequent Than We Think?
by: Umut Yılmaz, et al.
Published: (2024-01-01)

Impact of the COVID-19 pandemic on the regular follow-up and outcomes of patients with chronic myeloid leukemia in chronic-phase
by: Umut Yılmaz, et al.
Published: (2022-10-01)

Upregulation of SPINK2 in acute myeloid leukemia
by: Gezer Sümbül, et al.
Published: (2023-02-01)

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
by: Vyas, P, et al.
Published: (2015)

Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia
by: Jodi J. Lipof, et al.
Published: (2018-06-01)

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
by: Francesca Musumeci, et al.
Published: (2018-11-01)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
by: Narissa Parry, et al.
Published: (2022-11-01)

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience
by: Şeniz Öngören, et al.
Published: (2017-12-01)

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience
by: Şeniz Öngören, et al.
Published: (2017-11-01)

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
by: Shohei Mizuno, et al.
Published: (2024-04-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
by: Enrico Maffini, et al.
Published: (2022-11-01)

P390: ACUTE MYELOID LEUKEMIA SUPPRESSION BY PALBOCICLIB AND PONATINIB IN PATIENT-DERIVED XENOGRAFT
by: D. Busa, et al.
Published: (2022-06-01)

Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients
by: Dilhan Kuru, et al.
Published: (2011-09-01)

Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients
by: Dilhan Kuru, et al.
Published: (2011-08-01)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023-04-01)

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report
by: Nuno Cerveira, et al.
Published: (2018-12-01)

Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase
by: Binoy Yohanan, et al.
Published: (2022-12-01)

New‐onset posttransplant diabetes mellitus after haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide
by: Brendan L. Mangan, et al.
Published: (2020-11-01)

Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation
by: James M. Mathew, et al.
Published: (2024-02-01)

Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation presenting as pericardial effusion
by: Yuyan Shen, et al.
Published: (2023-10-01)

P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
by: Valentin Garcia Gutierrez, et al.
Published: (2023-08-01)

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience
by: Seniz Öngören, et al.
Published: (2018-11-01)

Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
by: Ahmet Emre Eşkazan, et al.
Published: (2013-12-01)

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
by: Kinstrie, R, et al.
Published: (2016)

How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation
by: Shan Jiang, et al.
Published: (2023-05-01)

Presenting a Prediction Model for Successful Allogenic Hematopoietic Stem Cell Transplantation in Adults with Acute Myeloid Leukemia
by: Mostafa Langarizadeh, et al.
Published: (2023-07-01)

Comparison of the efficacy of chemotherapy and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first remission in adults
by: S. N. Bondarenko, et al.
Published: (2015-09-01)

S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS
by: Ernesto José Cuenca Zamora, et al.
Published: (2023-08-01)

Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia
by: Vera Weeda, et al.
Published: (2022-09-01)

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
by: Oliver Schleicher, et al.
Published: (2022-09-01)

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia.
by: Sharareh Siamakpour-Reihani, et al.
Published: (2022-01-01)

Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01)

P379: PONATINIB AND BLINATUMOMAB IN RELAPSED/REFRACTORY PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR CHRONIC MYELOID LEUKEMIA IN LYMPHOID BLAST PHASE: SUBGROUP ANALYSIS FROM A PHASE II TRIAL
by: Fadi Haddad, et al.
Published: (2023-08-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
by: Karamitros, D, et al.
Published: (2016)

Dasatinib May Override F317L BCR-ABL Kinase Domain Mutation in Patients with Chronic Myeloid Leukemia
by: Ahmet Emre Eşkazan, et al.
Published: (2013-06-01)

Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP
by: Küçükyurt Selin, et al.
Published: (2024-02-01)

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring Rearrangement and Its Prognostic Factors
by: Bingqian Jiang, et al.
Published: (2024-01-01)

Characterization of Patients with Chronic Myeloid Leukemia Unresponsive to Tyrosine Kinase Inhibitors who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
by: Franceli Carvalho, et al.
Published: (2016-12-01)

Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies
by: Masamitsu Yanada, et al.
Published: (2022-11-01)

Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
by: Oliver Schleicher, et al.
Published: (2022-12-01)